Published in Medical Letter on the CDC and FDA, July 1st, 2007
The KARE project is expected to be one of the world's most recognizable clinical research projects. Researchers will use the Affymetrix microarray technology to generate individual genotypes from more than 10,000 human DNA samples. The technology enables...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA